Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway. (Q48465761)

11 February 2018

title

Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway. (English)

1 reference

11 February 2018

0 references

1 reference

Corinne Pellieux

1

1 reference

11 February 2018

Ellen Aasum

2

1 reference

11 February 2018

Terje S Larsen

3

1 reference

11 February 2018

Christophe Montessuit

4

1 reference

11 February 2018

Irène Papageorgiou

5

1 reference

11 February 2018

Thierry Pedrazzini

6

1 reference

11 February 2018

René Lerch

7

1 reference

11 February 2018

publication date

21 July 2006

1 reference

11 February 2018

Journal of Molecular and Cellular Cardiology

published in

1 reference

11 February 2018

volume

41

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

459-466

1 reference

11 February 2018

Does load-induced ventricular hypertrophy progress to systolic heart failure?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Fatty acid oxidation enzyme gene expression is downregulated in the failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Nuclear receptor signaling and cardiac energetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Saturated glucose uptake capacity and impaired fatty acid oxidation in hypertensive hearts before development of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

The renin-angiotensin system and experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Echocardiographic parameters discriminating myocardial infarction with pulmonary congestion from myocardial infarction without congestion in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Age-linked changes in the activity of enzymes of the tricarboxylate cycle and lipid oxidation, and of carnitine content, in muscles of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Myocardial substrate metabolism in the normal and failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

Peroxisome proliferator-activated receptors and cardiovascular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.004

10.1016/J.YJMCC.2006.06.004

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

16859699

1 reference

11 February 2018